Bayer Animal Health GmbH and Nutreco announced May 20 that they have signed a global research and development collaboration agreement to drive the development of novel technologies and applications for the animal health and animal nutrition industries.
According to the announcement, Bayer Animal Health and Nutreco share a common goal of developing game-changing solutions that promote animal well-being and sustainable farm profitability by enhancing the nutritional and health performance of farm animals.
The first joint project will focus on advancing innovative solutions for gastrointestinal health in dairy and beef cattle, the companies said.
Financial details have not been disclosed.
“Today’s agreement further demonstrates our strong commitment to drive innovation in the farm animal space. Joining forces with Nutreco will increase our innovative capabilities and leverage the development of new solutions for our customers. We look forward to furthering farm animal health and well-being and contributing to the sustainable development of the dairy and beef cattle industry,” said Dr. Douglas Hutchens, head of drug discovery, external innovation and chief veterinary officer at Bayer Animal Health.
The project will be run by Nutreco’s animal nutrition division, Trouw Nutrition. Saskia Korink, innovation director at Trouw Nutrition, explained, “We’re excited to be partnering with a company like Bayer to bring real breakthroughs in this area. By pooling our knowhow and capabilities, we can truly make significant steps forward and support farmers in growing their business in a sustainable way with animal well-being as a priority.”
The collaboration will enable both Bayer Animal Health and Nutreco to strengthen their respective farm animal product and solution portfolios, the announcement said.
Nutreco is a global leader in animal nutrition and aqua feed. Nutreco employs around 12,000 people in 37 countries with revenues of 6.4 billion euros in 2018. Its two global divisions Skretting (aqua feed) and Trouw Nutrition (animal nutrition) have sales in more than 90 countries. It is a wholly owned subsidiary of SHV Holdings N.V., a family-owned multinational with net sales of 20 billion euros in 2018.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In fiscal 2018, the group employed around 117,000 people and had sales of 39.6 billion euros.